Monitor CHF Patients at Home: CoVa Monitoring System 2 by ToSense
CoVa2 is the first FDA approved device for monitoring CHF patients at home after discharge from a hospital. Hemodynamic parameters include Heart Rate, Heart Rate Variability, Stroke Volume, Cardiac Output, Respiration Rate, Skin Temperature and Single Lead ECG. CoVa2 measures changes in chest fluids via Thoracic Impedance (TEB).
CoVa can predict the potential onset of CHF episodes by as much as 2 weeks over conventional methods. In its clinical trial, CoVa reduced CHF re-admissions 84% over 6 months.
CoVa is a Class 2 medical device and may only be sold to a provider or on a prescription from a physician. Learn more on our CoVa page and see our demonstration video. Read about the CPT Codes and ICD-10 diagnostic codes for CoVa.
SensoSCAN: Personal Wellness Monitoring
SensoSCAN is a personal wellness product. It is useful in helping people conveniently monitor their data supporting treatment compliance. It is not presently FDA cleared for diagnostic purposes.
SensoSCAN performs pulse oximeter functions, measures heart rate, breathing and does continuous blood pressure readings. Readings show on the device and on the gateway Sensogram App. The SensoSCAN information is available on an administrative platform.
See Sensogram.com for information.
Our company markets products and services to physicians, home health agencies, nursing homes, ACOs, and hospitals among the many provider organizations.